首页> 外国专利> Methods of treating, controlling or preventing specific cancer and a disease associated with unwanted angiogenesis and of reducing or preventing an adverse effect associated with the administration of a second active ingredient and with radiation therapy, hormone therapy, biological therapy or immunotherapy in a patient suffering from a specific cancer, pharmaceutical composition and kit

Methods of treating, controlling or preventing specific cancer and a disease associated with unwanted angiogenesis and of reducing or preventing an adverse effect associated with the administration of a second active ingredient and with radiation therapy, hormone therapy, biological therapy or immunotherapy in a patient suffering from a specific cancer, pharmaceutical composition and kit

机译:治疗,控制或预防特定癌症和与不想要的血管生成有关的疾病以及减少或预防与第二种活性成分的给药以及放疗,激素治疗,生物学治疗或免疫治疗有关的副作用的不良反应的方法具体的癌症,药物成分和试剂盒

摘要

"METHODS OF TREATING, CONTROLING OR PREVENTING A SPECIFIC CANCER AND DISEASE ASSOCIATED WITH AN UNGESTED ANGIOGENESIS AND REDUCING OR AVOIDING AN ADVERSE EFFECT ASSOCIATED WITH THERAPY THERAPY INGREDIENT AND THERAPEUTIC THERAPEUTIC THERAPY A PATIENT SUFFERING FROM A SPECIFIC CANCER, PHARMACEUTICAL COMPOSITION AND KIT ". Methods of treating, preventing and / or controlling cancer as well as diseases and disorders associated with or characterized by unwanted angiogenesis are described. Specific methods include administering a selective cytokine inhibitor drug alone or in combination with a second active ingredient. The invention relates in addition to methods of reducing or preventing adverse side effects associated with chemotherapy, radiation therapy, hormone therapy, biological therapy or immunotherapy comprising administering a selective cytokine inhibitor drug. Pharmaceutical compositions, individual unit dosage forms, and kits suitable for use in methods of the invention are also described.
机译:“治疗,控制或预防与不良的血管生成有关的特定癌症和疾病的方法,以及减少或避免与治疗疗法和治疗性疗法有关的不良影响,治疗性疗法和治疗方法,均由治疗性自疗法描述了治疗,预防和/或控制癌症以及与不希望的血管生成有关或以其为特征的疾病和失调的方法。具体方法包括单独或与第二活性成分组合施用选择性细胞因子抑制剂药物。本发明还涉及减少或预防与化学疗法,放射疗法,激素疗法,生物疗法或免疫疗法有关的不良副作用的方法,所述方法包括施用选择性细胞因子抑制剂药物。还描述了适用于本发明方法的药物组合物,单个单位剂型和试剂盒。

著录项

  • 公开/公告号BR0316057A

    专利类型

  • 公开/公告日2005-09-20

    原文格式PDF

  • 申请/专利权人 CELGENE CORPORATION;

    申请/专利号BR20030316057

  • 发明设计人 JEROME B. ZELDIS;

    申请日2003-11-06

  • 分类号A61K31/44;A61K31/425;A61K31/415;A61K31/40;

  • 国家 BR

  • 入库时间 2022-08-21 22:18:33

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号